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Background/Aims: This study investigated the prognostic power of corrected QT 
(QTc) interval in patients with acute heart failure (AHF) according to sex. 
Methods: We analyzed multicenter Korean Acute Heart Failure registry with 
patients with AHF admitted from 2011 to 2014. Among them, we analyzed 4,990 
patients who were followed up to 5 years. Regarding QTc interval based on 12 lead 
electrocardiogram, patients were classified into quartiles according to sex.
Results: During follow-up with median 43.7 months, 2,243 (44.9%) patients died. 
The relationship between corrected QT interval and all-cause mortality followed 
a J-curve relationship. In Kaplan-Meier analysis, both sex had lowest mortality in 
the second QTc quartile. There were significant prognostic differences between 
the second and the fourth quartiles in male (log-rank p = 0.002), but not in female 
(log-rank p = 0.338). After adjusting covariates, the third (hazard ratio [HR], 1.185; 
95% confidence interval [CI], 1.001 to 1.404; p = 0.049) and the fourth (HR, 1.404; 
95% CI, 1.091 to 1.535; p = 0.003) quartiles demonstrated increased risk of mortality 
compared to the second quartile in male. In female, however, there was no signif-
icant difference across quartiles. QTc interval was associated with 5-year all-cause 
mortality in J-shape with nadir of 440 to 450 ms in male and 470 to 480 ms in fe-
male. 
Conclusions: QTc interval was an independent predictor of overall death in male, 
but its significance decreased in female. The relationship between QTc interval 
and all-cause mortality was J-shaped in both sex.
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INTRODUCTION
Despite the advances in heart failure (HF) management, 
the associated mortality rate still remains substantially 
high [1-3]. When patients are hospitalized with acutely 
decompensated HF, they demonstrate high rates of re-
admission and mortality [4-7]. Therefore, various studies 
have been conducted to improve the precision of risk 
stratification in patients with acute HF [8,9]. Guidelines 
for the diagnosis and treatment of acute and chronic HF 
recommend an evaluation with 12-lead electrocardio-
gram (ECG) for all patients presenting with symptoms 
and signs of HF [10,11]. Clinical information obtained 
from ECG, such as heart rhythm, heart rate, QRS mor-
phology, and QT interval, assists in diagnosing cardiac 
abnormalities, making treatment decision, and predict-
ing prognosis. 
QT interval reflects the duration of ventricular depo-
larization and repolarization. Corrected QT (QTc) inter-
val is adjusted according to heart rate, which helps to 
identify patients with increased risk of ventricular ar-
rhythmia [12]. Left ventricular dilatation and female sex 
have been reported to be associated with QTc prolon-
gation [13,14]. Owing to their association with electrical 
instability and arrhythmogenesis, prolonged QT and 
QTc interval have been considered to be useful prog-
nosticators [15,16]. These intervals have shown prognos-
tic value, possibly with a J-shaped association, in healthy 
individuals as well as in those with risk factors [17-21]. 
Furthermore, these intervals have also been reported to 
have predictive value in patients with chronic HF [22,23].
On the contrary, a previous small and short cohort 
study in patients with acute HF failed to demonstrate 
significant association between prolonged QTc and 
mortality [24]. However, this study only performed bina-
ry risk stratification (QTc ≥ 440 ms or less), and did not 
consider QTc difference according to sex.
In this study, we hypothesized that QTc interval has 
useful prognostic value in patients with acute HF, and 
its association would be different according to sex. We 
categorized the patients in quartiles according to QTc 
interval and sex, and then investigated the prognostic 
value of QTc interval using 5-year follow-up data from 
Korean acute HF (KorAHF) registry. 
METHODS
The design of the KorAHF registry has been published 
elsewhere [2,3]. In brief, this multicenter cohort registry 
was designed to include consecutive patients admitted 
to the hospital with acute HF syndrome. Of the 5,625 
patients recruited between January 2011 and February 
2014, patients with QTc interval < 350 ms (n = 53), pacing 
rhythm (n = 134), and a previously diagnosed malignant 
neoplasm (n = 448) were excluded. Patients with the his-
tory of malignancy were excluded because their mortality 
was significantly different from that of patients without 
the history of malignancy. Final 4,990 patients were in-
cluded in the study. A schematic flowchart of this study 
is presented in Fig. 1. The Institutional Review Board of 
Seoul National University Hospital approved the study 
protocol (IRB No.: 2004-166-1119). Written informed 
consent by the patients was waived due to a retrospective 
nature of our study. The investigation conformed to the 
principles outlined in the Declaration of Helsinki. 
We recorded demographics, past medical history, so-
cial history, clinical presentation, and physical exam-
ination. Further, leukocytes, hemoglobin, blood urea 
nitrogen, creatinine, sodium, and potassium levels were 
measured and recorded at admission. Blood sampling 
and tests were conducted by laboratories at each center 
certified by the Korean Association of Quality Assurance 
for Clinical Laboratories. Transthoracic echocardiogra-
phy was performed by a skilled clinician upon admis-
sion. Data were entered into registry database through 
1st quartile (350 ≤ QTc ≤ 447 ms)
2nd quartile (447 < QTc ≤ 473 ms)
3rd quartile (473 < QTc ≤ 498 ms)
4th quartile ( QTc > 498 ms)
Exclusion
      53 Initial QTc interval < 350 ms or unavailable
    134 Pacing rhythm
    448 Previous history of malignancy
1st quartile (350 ≤ QTc ≤ 444 ms)
2nd quartile (444 < QTc ≤ 472 ms)
3rd quartile (472 < QTc ≤ 498 ms)
4th quartile ( QTc > 498 ms)
4,990 Analyzed acute heart failure patients
5,625 Enrolled acute heart failure patients
2,665 Male 2,325 Female
Figure 1. Scheme of the study. Scheme of this study is pre-
sented. QTc, corrected QT.
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a web-based case report form filled by the attending 
physician. Patients underwent standard 12-lead ECG 
evaluation upon admission. For this study we used clin-
ical QTc data obtained from these initial 12-lead ECG 
recordings, which were performed in real-world clinics. 
Patients were classified into quartiles according to sex; 
men were classified into 1st (350 ≤ QTc ≤ 447 ms), 2nd 
(447 < QTc ≤ 473 ms), 3rd (473 < QTc ≤ 498 ms), and 4th 
(QTc > 498 ms) quartiles and women were stratified into 
1st (350 ≤ QTc ≤ 444 ms), 2nd (444 < QTc ≤ 472 ms), 3rd 
(472 < QTc ≤ 498 ms), and 4th (QTc > 498 ms) quartiles.
Patients were followed up for 1, 3, 6, 12, 24, 36, 48, and 
60 months. All-cause mortality was used as a primary 
outcome variable in this study. Rate of any death or heart 
transplantation was the secondary outcome variable. 
Mortality data of patients who were lost to follow-up 
were collected from the governmental statistics office in 
South Korea. The primary endpoint was 5-year all-cause 
mortality, and we also analyzed 30-day mortality. In ad-
dition, we analyzed the 5-year and 30-day composite out-
comes of all-cause mortality and hospitalization due to 
heart failure.
Statistical analysis
Data were described as numbers and frequencies for 
categorical variables, and as mean ± standard deviation 
or median with interquartile range for continuous vari-
ables. For comparison between groups, the chi-square 
test or Fisher’s exact test was used for categorical vari-
ables and the unpaired Student’s t test was used for 
continuous variables. One-way analysis of variance and 
Scheffé’s post hoc test were used to analyze differences 
between continuous variables among > 2 groups. The 
chronological trend of outcomes was expressed as Ka-
plan–Meier estimates and compared according to the 
QTc interval. The log-rank test was used to analyze the 
significant differences in clinical outcomes. A multi-
variable Cox proportional-hazards regression mod-
el was used to find independent predictors of clinical 
outcomes. The associations between QTc interval and 
all-cause mortality were investigated using multivari-
able fractional polynomials (MFP). Two-sided p < 0.05 
was considered statistically significant. The IBM SPSS 
Statistics version 23 (IBM Co., Armonk, NY, USA) and 
STATA software version 12 (Stata Co., College Station, 
TX, USA) were used to perform statistical tests. 
RESULTS
Baseline characteristics of study population
The baseline characteristics of patients according to sex 
and QTc quartiles are described in Tables 1 and 2. Brief-
ly, the median follow-up period was 43.7 months and 
the mean age was 68.3 years, 53.4% of the subjects were 
males, 59.5% had hypertension, 36.0% had diabetes mel-
litus, and 28.8% had ischemic heart disease. In the study 
population, 42.4% of the subjects had been previously 
diagnosed with heart failure. There were no significant 
differences in age, previous history of hypertension, 
diabetes mellitus, heart failure, ischemic heart disease, 
chronic obstructive lung disease, chronic kidney dis-
ease, and cerebrovascular accident across the QTc quar-
tiles in both sex. Baseline characteristics according to 
sex are demonstrated in Supplementary Table 1.
Though previous report defined normal QTc group as 
QTc < 440 ms in patients with acute HF [24], the upper 
limit of 1st quartile surpass 440 ms in both male and 
female as shown in Tables 1 and 2. Left ventricular end 
diastolic diameter was significantly associated with QTc 
interval (r = 0.133, p < 0.001 for male and r = 0.181, p < 
0.001 for female). Age did not show significant correla-
tion with QTc interval (r = –0.006, p = 0.752 for male and 
r = –0.029, p = 0.160 for female) in both groups. LVEF was 
negatively associated with QTc interval in both sexes (r 
= –0.204, p < 0.001 for males and r = –0.225, p < 0.001 for 
females).
Clinical outcomes according to QTc quartiles during 
follow-up
During the 5-year follow-up period, 2,243 patients (44.9%) 
died, of which 1,185 (52.8%) were male. Among them, 268 
patients died during first 30 days. Subjects who died had 
more adverse characteristics, including older age, high-
er prevalence of previous hypertension, diabetes melli-
tus, heart failure, ischemic heart disease, valvular heart 
disease, chronic lung disease, chronic kidney disease, 
and cerebrovascular accident, than the survivors. De-
ceased subjects had larger left ventricular end diastolic 
diameter; however, there was no significant difference 
between the left ventricular ejection fractions of the liv-
ing and deceased subjects (Supplementary Table 2). 
Kaplan-Meier analysis was performed to demonstrate 
the clinical outcome of patients according to the QTc 
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Table 1. Baseline characteristics of male patients according to corrected QT Interval (total n = 2,665)
Characteristic
1st quartile
(350 ≤ QTc ≤ 447 ms)
(n = 685)
2nd quartile
(447 < QTc ≤ 473 ms)
(n = 666)
3rd quartile
(473 < QTc ≤ 498 ms)
(n = 649)
4th quartile




Age, yr 65.9 ± 15.1 64.7 ± 15.2 64.7 ± 65.8 65.8 ± 14.8 0.249
BMI, kg/m2 23.8 ± 3.8 23.6 ± 3.5 23.8 ± 4.1 23.3 ± 3.6 0.078
Past medical history
Hypertension 396 (57.8) 375 (56.3) 362 (55.8) 352 (53.0) 0.350
Diabetes mellitus 257 (37.5) 242 (36.3) 235 (36.2) 231 (34.8) 0.779
Heart failure 269 (39.3) 270 (40.5) 260 (40.1) 293 (44.1) 0.281
Ischemic heart disease 209 (30.5) 225 (33.8) 208 (32.0) 211 (31.9) 0.631
Valvular heart disease 90 (13.1) 71 (10.7) 73 (11.2) 74 (11.1) 0.499
COLD 109 (15.9) 84 (12.6) 73 (11.2) 86 (13.0) 0.080
CKD 113 (16.5) 99 (14.9) 117 (18.0) 85 (12.8) 0.056
Cerebrovascular 
 accident
105 (15.3) 115 (17.3) 93 (14.4) 116 (17.5) 0.339
Social history
Smoking history 0.062
Current smoker 194 (28.3) 236 (35.4) 192 (29.6) 204 (30.7)
Ex-smoker 251 (36.6) 234 (35.1) 222 (34.2) 235 (35.4)
Never smoker 240 (35.0) 196 (29.4) 235 (36.2) 225 (33.9)
Alcohol history 0.013
Heavy drinker 62 (9.1) 81 (12.2) 84 (12.9) 100 (15.1)
Social drinker 350 (51.1) 315 (47.3) 328 (50.5) 295 (44.4)
Never drinker 273 (39.9) 270 (40.5) 237 (36.5) 269 (40.5)
Major ECG abnormalities
Atrial fibrillation 207 (30.2) 165 (24.8) 165 (25.4) 165 (24.9) 0.067
Right bundle branch 
 block
19 (2.8) 26 (3.9) 55 (8.5) 122 (18.4) < 0.001
Left bundle branch 
 block
6 (0.9) 13 (2.0) 17 (2.6) 84 (12.5) < 0.001
NYHA functional class 0.482
Stage II 115 (16.8) 123 (18.5) 98 (15.1) 101 (15.2)
Stage III 247 (36.1) 248 (37.2) 247 (38.1) 236 (35.5)
Stage IV 323 (47.2) 295 (44.3) 304 (46.8) 327 (49.2)
Physical exam
SBP, mmHg 129.8 ± 29.6 131.1 ± 31.5 132.37 ± 30.8 127.0 ± 30.5 0.011
DBP, mmHg 76.5 ± 18.5 79.5 ± 19.1 80.7 ± 19.2 79.1 ± 20.0 0.001
HR, beats/min 87.9 ± 26.0 91.4 ± 24.3 94.6 ± 25.4 95.2 ± 26.8 < 0.001
Laboratory exam
Hemoglobin, mg/dL 14.6 ± 2.3 14.5 ± 2.4 14.7 ± 2.0 14.6 ± 1.9 0.360
Sodium, mmol/L 137.6 ± 4.7 137.9 ± 4.3 137.6 ± 4.5 137.0 ± 4.9 0.004
Potassium, mmol/L 4.4 ± 0.7 4.4 ± 0.6 4.4 ± 0.6 4.4 ± 0.7 0.618
BUN, mg/dL 26.7 ± 17.4 25.6 ± 15.9 26.8 ± 15.8 27.1 ± 16.5 0.336
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quartiles in both sex. In male, 2nd quartile not only 
showed highest survival rates but also showed signifi-
cantly superior prognosis compared to 4th quartile 
which had lowest survival rates (log-rank p = 0.002) (Fig. 
2A). On the contrary, there was no significant difference 
between 2nd and 4th quartiles (log-rank p = 0.338) in fe-
male (Fig. 2B). This tendency was also observed in the 
30-day mortality, as demonstrated in Fig. 3. When com-
posite outcomes of mortality and hospitalization due to 
heart failure were analyzed, only the 4th quartile of male 
patients showed increased risk at 5 years, with no prog-
nostic difference across quartiles seen in female patients 
(Supplementary Fig. 1).
Different prognostic impact of QTc quartiles ac-
cording to sex
The results of Cox-proportional regression analysis for 
5-year mortality were shown in Table 3. The 2nd quartile 
was defined as a reference group, as it had lowest risk 
in Kaplan-Meier analysis in both sex. Univariate analy-
sis showed increased risk of 4th quartile in male (hazard 
ratio [HR], 1.289; 95% confidence interval [CI], 1.095 to 
Characteristic
1st quartile
(350 ≤ QTc ≤ 447 ms)
(n = 685)
2nd quartile
(447 < QTc ≤ 473 ms)
(n = 666)
3rd quartile
(473 < QTc ≤ 498 ms)
(n = 649)
4th quartile
(QTc > 498 ms)
(n = 664)
p value




















Beta-blockers 203 (29.6) 181 (27.2) 158 (24.3) 174 (26.2) 0.181
Renin-angiotensin- 
 system inhibitors
270 (39.4) 256 (38.4) 225 (34.7) 259 (39.0) 0.270
Mineralocorticoid  
 receptor blockers
124 (18.1) 111 (16.7) 103 (15.9) 121 (18.2) 0.617
Medication at discharge
Beta-blockers 317 (46.2) 354 (53.2) 317 (48.8) 341 (51.5) 0.057
Renin-angiotensin- 
 system inhibitors
441 (64.3) 470 (70.6) 442 (68.1) 467 (70.3) 0.047
Mineralocorticoid 
 receptor blockers
262 (38.2) 294 (44.1) 313 (48.2) 318 (47.9) < 0.001
Echocardiographic findings
Left ventricular end 
 diastolic diameter, 
 mm
57.9 ± 10.0 60.6 ± 9.5 60.9 ± 9.9 61.2 ± 9.9 < 0.001
Ejection fraction, % 39.2 ± 15.5 34.6 ± 14.4 33.4 ± 14.1 30.8 ± 12.9 < 0.001
Heart failure with 
 reduced ejection 
 fraction (< 50%)
485 (73.8) 546 (84.5) 536 (85.8) 583 (91.0) < 0.001
Values are presented as mean ± SD, number (%), or median (range).
QTc, corrected QT; BMI, body mass index; COLD, chronic obstructive lung disease; CKD, chronic kidney disease; ECG, elec-
trocardiogram; NYHA, New York Heart association; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; 
BUN, blood urea nitrogen; BNP, B-type natriuretic peptide; NT-proBNP, N-terminal proBNP. 
Table 1. Continued
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Table 2. Baseline characteristics of female patients according to Corrected QT Interval (total n = 2,325)
Characteristic
1st quartile
(350 ≤ QTc ≤ 444 ms)
(n = 599)
2nd quartile
(444 < QTc ≤ 472 ms)
(n = 581)
3rd quartile
(472 < QTc ≤ 498 ms)
(n = 573)
4th quartile




Age, yr 72.1 ± 14.5 71.4 ± 13.5 72.1 ± 13.4 71.6 ± 13.8 0.750
BMI, kg/m2 23.0 ± 4.2 23.4 ± 4.0 23.0 ± 3.8 22.8 ± 4.2 0.038
Past medical history
Hypertension 368 (61.4) 387 (66.6) 380 (66.3) 348 (60.8) 0.066
Diabetes mellitus 209 (34.9) 216 (37.2) 212 (37.0) 194 (33.9) 0.586
Heart failure 260 (43.4) 253 (43.5) 256 (44.7) 252 (44.1) 0.972
Ischemic heart disease 139 (23.2) 152 (26.2) 163 (28.4) 128 (22.4) 0.067
Valvular heart disease 135 (22.5) 95 (16.4) 96 (16.8) 94 (16.5) 0.012
COLD 53 (8.8) 50 (8.6) 51 (8.9) 43 (7.5) 0.818
CKD 58 (9.7) 81 (13.9) 78 (13.6) 67 (11.7) 0.095
Cerebrovascular accident 95 (15.9) 77 (13.3) 81 (14.1) 89 (15.6) 0.553
Social history
Smoking history 0.534
Current smoker 23 (3.8) 25 (4.3) 32 (5.6) 30 (5.2)
Ex-smoker 20 (3.3) 16 (2.8) 24 (4.2) 16 (2.8)
Never smoker 556 (92.8) 540 (92.9) 517 (90.2) 526 (92.0)
Alcohol history 0.451
Heavy drinker 5 (0.8) 5 (0.9) 5 (0.9) 7 (1.2)
Social drinker 79 (13.2) 80 (13.8) 76 (13.3) 56 (9.8)
Never drinker 515 (86.0) 496 (85.4) 492 (85.9) 509 (89.0)
Major ECG abnormalities
Atrial fibrillation 207 (34.6) 184 (31.7) 150 (26.2) 148 (25.9) 0.002
Right bundle 
 branch block
11 (1.8) 24 (4.1) 29 (5.1) 74 (12.9) < 0.001
Left bundle branch block 5 (0.8) 9 (1.5) 24 (4.2) 112 (19.6) < 0.001
NYHA functional class 0.747
Stage II 87 (14.5) 86 (14.8) 79 (13.8) 69 (12.1)
Stage III 224 (37.4) 204 (35.1) 203 (35.4) 204 (35.7)
Stage IV 288 (48.1) 291 (50.1) 291 (50.8) 299 (52.3)
Physical exam
SBP, mmHg 133.5 ± 30.4 136.4 ± 31.0 134.6 ± 28.3 132.5 ± 29.9 0.151
DBP, mmHg 78.2 ± 18.2 80.1 ± 19.4 80.0 ± 18.2 79.1 ± 17.7 0.238
HR, beats/min 91.7 ± 27.8 94.1 ± 25.3 93.8 ± 24.6 94.1 ± 24.4 0.312
Laboratory exam
Hemoglobin, mg/dL 14.8 ± 2.2 14.6 ± 1.8 14.6 ± 1.7 14.7 ± 1.9 0.386
Sodium, mmol/L 137.2 ± 5.3 137.9 ± 4.5 137.9 ± 5.0 137.5 ± 5.0 0.068
Potassium, mmol/L 4.4 ± 0.7 4.4 ± 0.7 4.3 ± 0.7 4.2 ± 0.7 < 0.001
BUN, mg/dL 25.0 ± 16.6 25.1 ± 15.7 25.4 ± 14.7 26.0 ± 17.8 0.722
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1.516; p = 0.002). In female, no statistical significance was 
observed across the quartiles. 
We then evaluated the multivariate analysis, adjust-
ed for atrial fibrillation and right or left bundle branch 
block (model 1), and for comprehensive clinical data in-
cluding age, body mass index, previous history of hyper-
tension, diabetes mellitus, heart failure, ischemic heart 
disease, valvular heart disease, chronic obstructive lung 
disease, chronic renal failure, cerebrovascular accident, 
atrial fibrillation, beta-blocker medication at discharge, 
and right or left bundle branch block (model 2). With 
both models, 4th quartile in male had worse prognosis 
than reference group (HR, 1.252; 95% CI, 1.058 to 1.481; p = 
0.009 for model 1 and HR 1.404; 95% CI, 1.091 to 1.535; p = 
0.003 for model 2). In addition, 3th quartile in male also 
showed detrimental prognosis (HR, 1.185; 95% CI, 1.001 
to 1.404; p = 0.049) in model 2. However, there was no 
significant prognostic difference across QTc quartiles 
of female. The Cox model with MFP showed a J-shaped 
association in both male and female (Fig. 4). Male had 
nadir in about 440 to 450 ms, female in about 470 to 480 
ms with less steeper slope. When multivariate analyses 
were performed for 30-day mortality, there was no sig-




(350 ≤ QTc ≤ 444 ms)
(n = 599)
2nd quartile
(444 < QTc ≤ 472 ms)
(n = 581)
3rd quartile
(472 < QTc ≤ 498 ms)
(n = 573)
4th quartile
(QTc > 498 ms)
(n = 572)
p value
Creatinine, mg/dL 1.2 ± 0.9 1.3 ± 1.2 1.3 ± 1.5 1.3 ± 1.2 0.338



















Beta-blockers 170 (28.4) 200 (34.4) 186 (325) 148 (25.9) 0.006
Renin-angiotensin- 
 system inhibitors
239 (39.9) 225 (38.7) 228 (39.8) 188 (32.9) 0.042
Mineralocorticoid 
 receptor blockers
145 (24.2) 103 (17.7) 97 (16.9) 106 (18.5) 0.006
Medication at discharge
Beta-blockers 249 (41.6) 283 (48.7) 274 (47.8) 284 (49.7) 0.023
Renin-angiotensin- 
 system inhibitors
363 (60.6) 374 (64.4) 383 (68.6) 390 (68.2) 0.035
Mineralocorticoid 
 receptor blockers
264 (44.1) 246 (42.3) 270 (47.1) 286 (50.0) 0.046
Echocardiographic findings
Left ventricular end 
 diastolic diameter, mm
52.0 ± 8.7 53.3 ± 9.1 55.2 ± 8.9 57.1 ± 9.9 < 0.001
Ejection fraction, % 45.3 ± 15.9 44.0 ± 15.5 39.7 ± 15.3 36.4 ± 14.8 < 0.001
Heart failure with 
 reduced ejection 
 fraction (< 50%)
334 (57.7) 363 (64.5) 387 (71.1) 447 (80.5) < 0.001
Values are presented as mean ± SD, number (%), or median (interquartile range).
QTc, corrected QT; BMI, body mass index; COLD, chronic obstructive lung disease; CKD, chronic kidney disease; ECG, elec-
trocardiogram; NYHA, New York Heart association; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; 
BUN, blood urea nitrogen; BNP, B-type natriuretic peptide; NT-proBNP, N-terminal proBNP . 
Table 2. Continued
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Male: 5 years ACM
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Figure 2. Five-year outcomes according to corrected QT quartiles in acute heart failure patients. The Kaplan-Meier curves 
showed 5-year all-cause survival rates in (A) male and (B) female. ACM, all-cause mortality. 
Figure 3. Thirty-day outcomes according to corrected QT quartiles in acute heart failure patients. The Kaplan-Meier curves 
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DISCUSSION
The major findings of this study are as follows: (1) A 
substantial number of patients with acute HF had pro-
longed QTc interval (QTc ≥ 440 ms) than previously 
considered normal range; (2) in Kaplan-Meier analysis, 
prolonged QTc interval increases the 5-year mortality 
and 30-day mortality in male but not in female; (3) after 
adjusting covariates, QTc prolongation had indepen-
dent prognostic impact only in male, but its significance 
was attenuated in female; (4) there was J-shape associa-
tion between 5-year mortality in QTc interval in both 
male and female.
These findings were in congruence with previous 
Table 3. Unadjusted and adjusted Cox regression analysis for 5-year all-cause death
Variable
Univariate analysis Model 1a Model 2b 
HR (95% CI) p HR (95% CI) p HR (95% CI) p
Male
1st quartile 1.166 (0.991–1.373) 0.065 1.164 (0.988–1.371) 0.069 1.158 (0.981–1.366) 0.084
2nd quartile Reference Reference Reference
3rd quartile 1.148 (0.972–1.355) 0.105 1.142 (0.967–1.349) 0.118 1.185 (1.001–1.404) 0.049
4th quartile 1.289 (1.095–1.516) 0.002 1.252 (1.058–1.481) 0.009 1.404 (1.091–1.535) 0.003
Female
1st quartile 1.152 (0.972–1.366) 0.102 1.148 (0.968–1.361) 0.113 1.089 (0.916–1.295) 0.332
2nd quartile Reference Reference Reference
3rd quartile 1.128 (0.949–1.340) 0.171 1.136 (0.956–1.351) 0.147 1.072 (0.901–1.276) 0.433
4th quartile 1.089 (0.915–1.296) 0.335 1.074 (0.895–1.290) 0.442 1.021 (0.849–1.229) 0.824
HR, hazard ratio; CI, confidence interval.
aMultivariate analysis were calculated by Cox regression models, including atrial fibrillation and right or left bundle branch 
block.
bMultivariate analysis were calculated by Cox regression models, including age, body mass index, previous history of hyperten-
sion, diabetes mellitus, heart failure, ischemic heart disease, valvular heart disease, chronic obstructive lung disease, chronic 
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Figure 4. Thirty-day outcomes according to corrected QT (QTc) quartiles in acute heart failure patients. The Kaplan-Meier 
curves showed 30-day all-cause survival rates in (A) male and (B) female. HR, hazard ratio.
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studies which demonstrated increased mortality risk in 
chronic HF patients with prolonged QT interval [22,23]. 
Furthermore, our study found that a substantial number 
of patients had prolonged QTc interval, and the nadir of 
J-shaped association was significantly right-shifted in 
patients with acute HF compared to those with chronic 
HF [22]. This discrepancy could have influenced the re-
sults of a previous study that reported lack of prognos-
tic impact of QTc interval and absence of of J-shaped 
association, as aforementioned study analyzed the QTc 
duration only by a binary classification based on the 440 
ms threshold [24]. We did not explore the underlying bi-
ology linking QTc interval and mortality in this study. 
To our knowledge, there is a paucity of data which could 
directly explain this J-shaped relationship. Based on the 
findings of several experimental studies, the authors 
cautiously suggest that a relatively short QTc duration 
and repolarization time could be a substrate for multi-
ple-circuit reentry excitation, which would induce atri-
al/ventricular arrhythmia [25,26].
Right shifted QTc interval range with low risk of all-
cause mortality, as shown in the lowest mortality of 2nd 
quartile, might be attributed to the complex character-
istics of acute HF. Patients with acute HF experience a 
decline in pumping capacity, which results in hypoper-
fusion and congestion. Compensatory pathways, in-
cluding the renin-angiotensin system and sympathetic 
nervous system, are then activated to maintain cardiac 
output by increasing salt retention and augmented car-
diac contractility [27,28]. Although sustained compen-
satory mechanisms could lead to pathologic end-organ 
damage, their activation is important for the restoration 
of the cardiovascular status within the hemodynamical-
ly stable physiologic range and renders patients asymp-
tomatic in the short acute period [24]. The QTc inter-
val represents the time of electrical depolarization and 
repolarization of ventricular myocardium. However, 
as shown in Table 3, QTc interval persistently demon-
strated prognostic implications even after adjusting for 
multiple comorbidities, including left ventricular end 
diastolic diameter. Therefore, we hypothesize that QTc 
interval could be influenced by various environmental 
factors, in addition to the left ventricular dimension. 
Studies have demonstrated that the QTc interval could 
vary according to sympathetic and parasympathetic 
tone [29,30]. In particular, increased catecholamine lev-
els, which could often be observed in patients with acute 
heart failure, have been reported to induce QTc interval 
Table 4. Unadjusted and adjusted Cox regression analysis for 30-day all-cause death
Variable
Univariate analysis Model 1a Model 2b
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Male
1st quartile 1.232 (0.769–1.974) 0.386 1.280 (0.798–2.052) 0.306 1.174 (0.730–1.889) 0.507
2nd quartile Reference Reference Reference
3rd quartile 1.437 (0.906–2.281) 0.124 1.404 (0.884–2.230) 0.151 1.336 (0.837–2.132) 0.225
4th quartile 1.610 (1.027–2.525) 0.038 1.432 (0.896–2.290) 0.133 1.368 (0.851–2.199) 0.196
Female
1st quartile 1.350 (0.770–2.368) 0.295 1.368 (0.780–2.400) 0.274 1.131 (0.639–2.001) 0.674
2nd quartile Reference Reference Reference
3rd quartile 1.307 (0.739–2.311) 0.358 1.280 (0.723–2.266) 0.398 1.221 (0.689–2.164) 0.493
4th quartile 1.420 (0.810–2.490) 0.221 1.355 (0.753–2.440) 0.311 1.338 (0.744–2.408) 0.331
HR, hazard ratio; CI, confidence interval.
aMultivariate analysis were calculated by Cox regression models, including atrial fibrillation and right or left bundle branch 
block.
bMultivariate analysis were calculated by Cox regression models, including age, body mass index, previous history of hy-
pertension, diabetes mellitus, heart failure, ischemic heart disease, valvular heart disease, chronic obstructive lung disease, 
chronic renal failure, cerebrovascular accident, atrial fibrillation, beta-blocker medication at discharge, and right or left bun-
dle branch block.
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prolongation [31-33]. Change in QTc interval in patients 
with acute HF might be confounded by its complex 
pathophysiologic status, not only with respect to struc-
tural abnormality, but also with respect to adaptively ac-
tivated neurohormonal pathways, which were different 
from those in participants of other studies.
A variety of studies have reported significantly lon-
ger QTc intervals in females compared to their male 
counterparts [34,35], in those of normal status as well as 
those with various pathologies [36,37]. These studies sug-
gested that sex hormone differences between male and 
female could have an influence on ventricular repolar-
ization. Therefore, we postulated that the QTc interval 
of females might be longer than that of males among 
patients with AHF, and set the quartiles separately for 
males and females. 
We found that prolonged QTc interval has a prog-
nostic implication in males, but its significance was di-
minished in females. Although we did not fully explore 
the underlying biological mechanisms, there are several 
possible explanations for our results. Female patients 
showed a higher percentage of heart failure with pre-
served ejection fraction (HFpEF) than male patients. 
When we analyzed the multifractional polynomial Cox 
regression according to HF phenotypes, we found that 
the J-curve association was steeper in the upper limits 
in patients with heart failure with reduced ejection frac-
tion compared to those with HFpEF. In addition, female 
patients were older and showed a preponderance of a 
previous history of hypertension, heart failure and val-
vular heart disease (Supplementary Table 1), which were 
frequently observed in deceased subjects (Supplemen-
tary Table 2). Considering these together, we cautiously 
hypothesize that these detrimental covariates might at-
tenuate the statistical significance of the QTc interval in 
female patients.
In this study, we adopted the QTc interval measured 
and calculated automatically by standard commercial 
electrographs. However, several previous studies on QT 
or QTc interval measured the duration of QT interval 
manually [12,22,24,38,39]. These manual methods are not 
real-world clinical practices, are time-consuming pro-
cesses, and demonstrated physician dependency (even 
among trained cardiologists) [40,41]. In addition, auto-
matic method has recently proved its usefulness and ac-
curacy in QT interval measurement [42,43].
This study provides an insight into the association 
between QTc duration and all-cause mortality. While 
accurate cause of the right-shifted relation cannot be 
fully understood through our report, our findings have 
valuable clinical implications. QTc duration can be eas-
ily obtained and measured with a 12-lead ECG or even 
mobile devices. However, such simple measurement 
can predict the prognosis in high risk patients. It could 
be helpful to stratify the risk of patients in addition to 
other risk factors without invasive procedure [8,9]; for 
example, it might be applied in tele-monitoring.
Some limitations of this study must be taken into con-
sideration. First, the onset of prolonged QTc and the ef-
fect of dynamic QTc interval change during follow-up 
were unknown in our registry. Second, we did not an-
alyze the confounding effect of antiarrhythmic agents 
such as amiodarone for atrial fibrillation and antide-
pressants, which might induce QTc interval prolonga-
tion [21,22]. However, the J-shaped relationship of QTc 
interval and all-cause mortality persisted regardless of 
atrial fibrillation, which accounted for most type III 
medication use. This issue appeared minor. In addition, 
since the patients in this study all come from East Asia, 
it is unknown whether the results of this study can be 
extrapolated to other ethnicities and countries. Fourth, 
we used QTc data obtained by real-world 12-lead ECG 
devices. This study was intended to show the practical 
prognostic value of the QTc interval, but there could be 
confounders in patients with atrial fibrillation and bun-
dle branch block, although these factors were adjusted 
for in the multivariable analysis. In addition, since we 
did not assess all echocardiographic parameters regard-
ing LV mass, we could not investigate the association 
between QTc interval and LV mass index. Lastly, we ex-
cluded patients with pacing rhythm, as their activation 
and deactivation pathway might be different from that 
of those without artificial pacing.
In conclusion, a substantial number of patients with 
AHF had prolonged QTc interval. QTc interval is an in-
dependent prognosticator for 5-year mortality in male, 
but it failed to show prognostic significance in female. 
The relationship between QTc interval and all-cause 
mortality was J-shaped as was previously known; how-
ever, it seemed to be right-shifted in patients with AHF 
and less steeper in female.
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Supplementary Table 1. Baseline characteristics according to sex (total n = 4,990)
Characteristic Male (n = 2,665) Female (n = 2,325) p value
Demographic data
Age, yr 65.3 ± 14.8 71.8 ± 13.8 < 0.001
Body mass index, kg/m2 23.6 ± 3.8 23.1 ± 4.0 < 0.001
Past medical history
Hypertension 1,486 (55.8) 1,483 (63.8) < 0.001
Diabetes mellitus 996 (36.2) 83 (35.7) 0.710
Heart failure 1,093 (41.0) 1,021 (43.9) 0.039
Ischemic heart disease 853 (32.0) 582 (25.0) < 0.001
Valvular heart disease 309 (11.6) 420 (18.1) < 0.001
Chronic obstructive lung disease 352 (13.2) 197 (8.5) < 0.001
Chronic kidney disease 414 (15.5) 284 (12.2) 0.001
Cerebrovascular accident 429 (16.1) 342 (14.7) 0.174
Social history
Smoking history < 0.001
Current smoker 826 (31.0) 110 (4.7)
Ex-smoker 942 (35.3) 76 (3.3)
Never smoker 897 (33.7) 2,139 (92.0)
Alcohol history
Heavy drinker 327 (12.3) 22 (0.9)
Social drinker 1,289 (48.4) 291 (12.5)
Never drinker 1,049 (39.4) 2,012 (86.5)
Major ECG abnormalities
Atrial fibrillation 703 (26.4) 689 (29.6) 0.011
Right bundle branch block 222 (8.3) 138 (5.9) 0.001
Left bundle branch block 119 (4.5) 150 (6.5) 0.002
NYHA functional class 0.013
Stage II 437 (16.4) 321 (13.8)
Stage III 978 (36.7) 835 (35.9)
Stage IV 1,250 (46.9) 1,169 (50.3)
Physical exam
SBP, mmHg 130.1 ± 30.7 134.3 ± 29.9 < 0.001
DBP, mmHg 78.9 ± 19.3 79.3 ± 18.4 0.403
HR, beats/min 92.2 ± 25.8 93.4 ± 25.6 0.110
Laboratory exam
Hemoglobin, mg/dL 14.6 ± 2.2 14.7 ± 1.9 0.272
Sodium, mmol/L 137.6 ± 4.6 137.6 ± 5.0 0.681
Potassium, mmol/L 4.4 ± 0.7 4.3 ± 0.7 < 0.001
BUN, mg/dL 26.5 ± 16.4 25.4 ± 16.2 0.013
Creatinine, mg/dL 1.6 ± 1.7 1.3 ± 1.2 < 0.001
BNP, pg/mL 854.0 (443.0–1,667.0) 936.0 (504.4–1,821.8) 0.115
NT-proBNP, pg/mL 4,349.0 (1,975.0–10,301.0) 5,366.0 (2,379.0–13,763.0) < 0.001
Medication at admission
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Characteristic Male (n = 2,665) Female (n = 2,325) p value
Beta-blockers 716 (26.9) 704 (30.3) 0.008
Renin-angiotensin-system inhibitors 1,010 (37.9) 880 (37.8) 0.971
Mineralocorticoid receptor blockers 459 (17.2) 451 (19.4) 0.047
Medication at discharge
Beta-blockers 1,330 (49.9) 1,090 (46.9) 0.033
Renin-angiotensin-system inhibitors 1,820 (68.3) 1,510 (64.9) 0.012
Mineralocorticoid receptor blockers 1,187 (44.5) 1,066 (45.8) 0.354
Echocardiographic findings
Left ventricular end diastolic diameter, mm 60.1 ± 9.9 54.4 ± 9.3 < 0.001
Ejection fraction, % 34.6 ± 14.6 41.4 ± 15.8 < 0.001
Heart failure with reduced ejection fraction 
 (< 50%)
2,150 (83.7) 1,531 (68.3) < 0.001
Values are presented as mean ± SD, number (%), or median (interquartile range).
ECG, electrocardiogram; NYHA, New York Heart association; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, 
heart rate; BUN, blood urea nitrogen; BNP, B-type natriuretic peptide; NT-proBNP, N-terminal proBNP. 
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Supplementary Table 2. Baseline characteristics of subjects according to 5-year survival (total n = 4,990)
Characteristic Alive (n = 2,747) Deceased (n = 2,243) p value
Demographic data
Age, yr 63.7 ± 15.0 74.0 ± 12.2 < 0.001
Sex, men 1,480 (53.9) 1,185 (52.8) 0.461
Body mass index, kg/m2 24.1 ± 3.9 22.5 ± 3.7 < 0.001
Past medical history
Hypertension 1,474 (53.7) 1,495 (66.7) < 0.001
Diabetes mellitus 864 (31.5) 933 (41.6) < 0.001
Heart failure 930 (33.9) 1,184 (52.8) < 0.001
Ischemic heart disease 615 (22.4) 820 (36.6) < 0.001
Valvular heart disease 376 (13.7) 353 (15.7) 0.042
Chronic obstructive lung disease 242 (8.8) 307 (13.7) < 0.001
Chronic kidney disease 232 (8.4) 466 (20.8) < 0.001
Cerebrovascular accident 310 (11.3) 461 (20.6) < 0.001
Social history
Smoking history < 0.001
Current smoker 552 (37.3) 274 (23.1)
Ex-smoker 472 (31.9) 470 (39.7)
Never smoker 456 (30.8) 441 (37.2)
Alcohol history < 0.001
Heavy drinker 233 (15.1) 104 (8.8)
Social drinker 780 (52.7) 509 (43.0)
Never drinker 477 (32.2) 572 (48.3)
Major ECG abnormalities
Atrial fibrillation 965 (35.1) 804 (35.8) 0.599
Right bundle branch block 188 (6.8) 172 (7.7) 0.263
Left bundle branch block 138 (5.0) 131 (5.8) 0.204
NYHA functional class < 0.001
Stage II 515 (18.7) 243 (10.8)
Stage III 1,039 (37.8) 774 (34.5)
Stage IV 1,193 (43.4) 1,226 (54.7)
Physical exam
SBP, mmHg 132.5 ± 29.9 131.5 ± 31.0 0.255
DBP, mmHg 80.5 ± 19.1 77.3 ± 18.4 < 0.001
HR, beats per min 93.5 ± 26.2 91.9 ± 25.1 0.037
Laboratory exam
Hemoglobin, mg/dL 14.3 ± 1.9 15.1 ± 2.1 < 0.001
Sodium, mmol/L 138.3 ± 4.3 136.7 ± 5.2 < 0.001
Potassium, mmol/L 4.3 ± 0.6 4.5 ± 0.8 < 0.001
BUN, mg/dL 22.6 ± 13.8 30.1 ± 18.2 < 0.001
Creatinine, mg/dL 1.3 ± 1.4 1.7 ± 1.5 < 0.001
BNP, pg/mL 728.1 (392.7–1,341.8) 1,117.3 (595.6–2,289.0) < 0.001
NT-proBNP, pg/mL 3,541.0 (1,561.0–7,627.8) 7,222.0 (3,342.3–17,506.2) < 0.001
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Characteristic Alive (n = 2,747) Deceased (n = 2,243) p value
Medication at admission
Beta-blockers 734 (26.7) 686 (30.6) 0.003
Renin-angiotensin-system inhibitors 966 (35.2) 924 (41.2) < 0.001
Mineralocorticoid receptor blockers 435 (15.8) 475 (21.2) < 0.001
Medication at discharge
Beta-blockers 1,493 (54.4) 927 (41.3) < 0.001
Renin-angiotensin-system inhibitors 1,964 (71.5) 1,366 (60.9) < 0.001
Mineralocorticoid receptor blockers 1,315 (47.9) 938 (41.8) < 0.001
Echocardiographic findings
Left ventricular end diastolic diameter, mm 57.8 ± 9.9 57.0 ± 10.3 0.005
Ejection fraction, % 37.8 ± 15.7 37.7 ± 15.3 0.888
Heart failure with reduced ejection fraction 
 (< 50%)
2,035 (75.9) 1,646 (77.3) 0.265
Values are presented as mean ± SD, number (%), or median (interquartile range).
ECG, electrocardiogram; NYHA, New York Heart association; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, 
heart rate; BUN, blood urea nitrogen; BNP, B-type natriuretic peptide; NT-proBNP, N-terminal proBNP. 
Supplementary Table 2. Continued













































Male: 5 years ACM + HHF Female: 5 years ACM + HHF
Male: 30 days ACM + HHF Female: 30 days ACM + HHF
Quartile



























































































































































































































Supplementary Figure 1. Composite outcomes of all-cause mortality (ACM) and hospitalization due to heart failure (HHF) ac-
cording to corrected QT (QTc) quartiles in acute heart failure patients. (A) Male: 5 years ACM + HHF. (B) Female: 5 years ACM + 
HHF. (C) Male: 30 days ACM + HHF. (D) Female: 30 days ACM + HHF. The Kaplan-Meier curves showed 5-year and 30-day out-
comes in male and female patients.
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